These results suggest that CTSLP8 interacts with PKM2 to regulate the c-Myc oncogene, resulting in increased cellular glycolysis and contributing to the progression of ovarian cancer and the development of chemotherapy resistance. Here, CTSLP8 is linked to ovarian cancer.